CBX6 and chronic myelogenous leukemia, BCR-ABL1 positive: CBX6 may act as a tumor suppressor in chronic myeloid leukemia (CML), as its expression levels are low in untreated CML patients but increase during treatment with tyrosine kinase inhibitors (TKIs) used to manage the disease.